NASDAQ: ADAP       Adaptimmune Ther Ads
Last Price Today's Change   Day's Range   Trading Volume
0.851   -0.019 (2.18%)  0.851 - 0.931  74,498


Avg Volume (4 weeks):331,585
4 Weeks Range:0.709 - 1.17
4 Weeks Price Volatility (%):
52 Weeks Range:0.709 - 6.55
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Adaptimmune Therapeutics PLC is UK based biopharmaceutical company focused on novel cancer immunotherapy products based on its proprietary Specific Peptide Enhanced Affinity Receptor T-cell platform. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. The company engineers TCRs to increase their affinity to cancer-specific peptides in order to destroy cancer cells in patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.

  Be the first to like this.


1667  3771  632  2907 

Top 10 Active Counters
 CELG 108.24+0.11 
 AABA 19.630.00 
 ACB 3.015+0.375 
 AMD 40.064-0.916 
 UBER 29.58+1.55 
 M 14.54-0.48 
 HEPA 3.702+1.282 
 CHK 0.579+0.008 
 SCHW 48.51+3.76 
 AMTD 49.405+8.025 
Partners & Brokers